Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Paclitaxel,Carboplatin
Therapeutic Area : Oncology
Study Phase : Approved FDF
Sponsor : Elevar Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Details : Tiba will be responsible for managing named-patient requests through which physicians can legally and ethically prescribe Apealea for patients prior to commercial availability, commercialize and distribute the product throughout the Middle East and North...
Product Name : Apealea
Product Type : Cytotoxic Drug
Upfront Cash : Undisclosed
May 10, 2020
Lead Product(s) : Paclitaxel,Carboplatin
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Sponsor : Elevar Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement